SGA
ALNY icon

Sector Gamma AS’s Alnylam Pharmaceuticals ALNY Stock Holding History

Sector Gamma AS’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,240
Closed -$3.7M – 31
2024
Q2 		$3.7M Sell
15,240
-12,343
-45% -$1.95M 1.38% 24
2024
Q1 		$4.12M Sell
27,583
-4,509
-14% -$752K 1.16% 25
2023
Q4 		$6.14M Sell
32,092
-20,876
-39% -$3.56M 1.49% 23
2023
Q3 		$9.38M Buy
52,968
+24,901
+89% +$4.75M 2.4% 17
2023
Q2 		$5.33M Buy
28,067
+678
+2% +$134K 1.19% 23
2023
Q1 		$5.49M Buy
+27,389
New +$5.76M 1.33% 24
2022
Q4 		– Sell
-6,921
Closed -$1.39M – 32
2022
Q3 		$1.39M Sell
6,921
-35,923
-84% -$6.85M 0.36% 29
2022
Q2 		$6.25M Sell
42,844
-16,407
-28% -$2.33M 1.4% 21
2022
Q1 		$9.68M Buy
+59,251
New +$9.03M 2.1% 17
2021
Q3 		– Sell
-58,017
Closed -$9.84M – 30
2021
Q2 		$9.84M Sell
58,017
-1,772
-3% -$260K 1.74% 24
2021
Q1 		$8.44M Buy
59,789
+30,174
+102% +$4.54M 1.55% 23
2020
Q4 		$3.85M Buy
29,615
+10,124
+52% +$1.35M 0.73% 28
2020
Q3 		$2.84M Sell
19,491
-22,193
-53% -$3.15M 0.65% 26
2020
Q2 		$6.17M Sell
41,684
-12,700
-23% -$1.71M 1.27% 25
2020
Q1 		$5.92M Buy
+54,384
New +$6.28M 1.26% 27
2019
Q4 		– Sell
-96,900
Closed -$7.79M – 38
2019
Q3 		$7.79M Buy
96,900
+25,000
+35% +$1.98M 1.32% 28
2019
Q2 		$5.22M Buy
+71,900
New +$5.52M 0.84% 31
2019
Q1 		– Sell
-59,437
Closed -$4.33M – 34
2018
Q4 		$4.33M Buy
59,437
+14,000
+31% +$1.08M 0.73% 30
2018
Q3 		$3.98M Buy
45,437
+12,937
+40% +$1.3M 0.62% 27
2018
Q2 		$3.2M Buy
+32,500
New +$3.22M 0.53% 27
2018
Q1 		– Sell
-9,400
Closed -$1.19M – 31
2017
Q4 		$1.19M Buy
+9,400
New +$1.18M 0.2% 36

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sector Gamma AS's ALNY Position: Q3 2024 in Review

Sector Gamma AS sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2024, closing a stake of 15,240 shares — an estimated $3.7M sold.

Sector Gamma AS first reported a position in ALNY in Q4 2017 and held it in 21 quarters. The position peaked at $9.84M in Q2 2021. 566 funds tracked by Wall St. Rank hold ALNY as of Q3 2024.

  • Sector Gamma AS reported no remaining Alnylam Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Sector Gamma AS sold 15,240 Alnylam Pharmaceuticals shares in Q3 2024, an estimated $3.7M.
  • Sector Gamma AS first reported a position in Alnylam Pharmaceuticals in Q4 2017 and held it in 21 quarters.
  • Sector Gamma AS's Alnylam Pharmaceuticals position peaked at $9.84M in Q2 2021.
  • 566 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2024.

Based on Sector Gamma AS's 13F filing for Q3 2024, filed 13 Nov 2024.